Related Experiment Videos

C-reactive protein, stroke, and statins

Allan D Angerio1, Matthew F Bialko, Bradley M White

  • 1School of Nursing and Health Studies, Georgetown University, Washington, DC 20057, USA. angerioa@georgetown.edu

Critical Care Nursing Quarterly
|March 16, 2007
PubMed

Insights

C-reactive protein (CRP) indicates inflammation and may play a role in early stroke development. Monitoring CRP levels and using statins could help prevent and treat stroke.

Area of Science:

  • Biomedical science
  • Clinical research
  • Inflammatory disease mechanisms

Background:

  • C-reactive protein (CRP) is a key biomarker in systemic inflammation.
  • Inflammatory processes are implicated in the pathogenesis of cerebrovascular diseases, including stroke.

Purpose of the Study:

  • To investigate the role of C-reactive protein (CRP) in the early stages of stroke.
  • To evaluate the potential of CRP monitoring for stroke prevention and treatment.
  • To assess the impact of statin therapy on CRP levels and stroke incidence.

Main Methods:

  • Review of existing literature on CRP and stroke.
  • Analysis of clinical data correlating CRP levels with stroke events.
  • Examination of studies on statin efficacy in modulating CRP and stroke risk.

Main Results:

  • CRP is identified as a significant indicator in inflammatory conditions like stroke.
  • Evidence suggests CRP involvement in the initial phases of stroke.
  • Statin medications show potential in reducing both CRP levels and stroke occurrence.

Conclusions:

  • CRP monitoring offers a potential strategy for stroke prevention and management.
  • Statin therapy may be a valuable intervention for mitigating stroke risk through CRP level reduction.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...